Kornelsen Michael purchased $250 of LCTC

Kornelsen Michael purchased 100 shares of Lifeloc Technologies, Inc (LCTC) at $2.50 on 2026-06-16.

Original reporting
SEC EDGAR · Kornelsen Michael
Published Jun 25, 2026, 1:36 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 25, 2026, 2:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LCTC
Bullish
low confidence
Mentioned
$LCTC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LCTCBullishLow
01

Why it matters

This provides a fresh datapoint on insider activity but does not include any new company performance, guidance, or regulatory/contract developments.

02

Market read

Traders may note mild sentiment from insider buying, but the transaction’s small size limits tradable impact.

03

What to watch

Insider buys can be offset by other insider sales not shown here; also, the filing date may lag the market’s reaction to the underlying trade date.

Relevance 4/10Novelty 3/10Timing: SEC Form 4 filed 2026-06-24 for a 2026-06-16 purchase.

Background

The article is an SEC Form 4 insider transaction disclosure for Lifeloc Technologies, Inc.

Company-level read

Ticker impact

$LCTCBullishLow confidence
Context

Director Kornelsen Michael filed a Form 4 open-market purchase of 100 shares at $2.50 on 2026-06-16, holdings now 1,100.

Expected impact

Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around the filing.

Evidence & confidence

The transaction size is small ($250) and the filing is a routine insider Form 4 without new operational or financial guidance.

Market effects

No sector read-across; this is a company-specific, small insider transaction.

None indicated.

None indicated.

Counterpoint

The purchase may be routine (e.g., personal liquidity planning) and not a strong signal of improved fundamentals given the lack of a 10b5-1 plan and the small dollar amount.

Key entities

  • Lifeloc Technologies, Inc

    Subject of the Form 4 insider transaction; director Kornelsen Michael purchased 100 shares at $2.50.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LCTCMed

Lifeloc Reports Third Quarter 2026 Results

Lifeloc Technologies, Inc (LCTC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lifeloc Reports Third Quarter 2026 Results WHEAT RIDGE, Colo., November 16, 2026 -- Lifeloc Technologies, Inc. (OTCID: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quar

$LCTCMed

Lifeloc Reports Second Quarter 2026 Results

Lifeloc Technologies, Inc (LCTC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lifeloc Reports Second Quarter 2026 Results WHEAT RIDGE, Colo., August 13, 2026 -- Lifeloc Technologies, Inc. (OTCID: LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quart